Cinclus Pharma ^Company

Cinclus Pharma AG is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. The company's lead product, X842 has been studied in a Phase I clinical trial for the treatment of severe erosive Gastroesophageal reflux disease.